Human trials of third homegrown COVID-19 vaccine to begin in March

The highest dose, 75mcg, of Nanocovax was given to volunteers in Ha Noi on January 12. (Photo: VOV)

The vaccine is developed by Vaccine and Biological Production No. 1 (VABIOTECH). It is one of the four companies that are developing COVID-19 vaccines in Viet Nam, along with the Institute of Vaccines and Medical Biologicals (IVAC), the Centre for Research and Production of Vaccines and Biologicals (POLYVAC), and Nanogen Pharmaceutical Biotechnology (NANOGEN).

Nanocovax by NANOGEN is Viet Nam’s first candidate vaccine against the novel coronavirus SARS-CoV-2 to reach the human trial stage.

The highest dose, 75mcg, of Nanocovax was given to three volunteers in Ha Noi on January 12.

The Nha Trang-based IVAC has also been authorised to carry out human clinical tests for its Covivac.

According to Associate Professor Dr. Chu Van Men, Director of the Military Medical University’s Centre for Clinical Trials and Bioequivalence, Viet Nam expects to collect all necessary data on clinical testing by the end of 2021 before it can consider mass vaccination.

Da Lat aims to welcome more than 4 million visitors in 2021 The resort city of Da Lat in the Central Highlands province of Lam Dong aims to welcome more than 4 million visitors, including 150,000 foreigners ...

Viet Nam stands firm amid COVID-19 pandemic: International media Foreign media have run several articles highlighting Viet Nam’s economic success given a struggling world plagued by the COVID-19 pandemic.

Vietnamese citizens advised to avoid countries with new COVID-19 variant Viet Nam has recently warned its citizens not to travel to places that have confirmed cases of the latest novel coronavirus (COVID-19) variant, with the ...